Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Warren T. Blume is active.

Publication


Featured researches published by Warren T. Blume.


Epilepsia | 2002

Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology.

Warren T. Blume; Hans O. Lüders; Eli M. Mizrahi; Carlo Tassinari; Walter van Emde Boas; Jerome Engel

INTRODUCTION PRINCIPLES FOR TERMS AND DEFINITIONS DATA SOURCES I GENERAL TERMS 1.0 SEMIOLOGY 2.0 EPILEPTIC SEIZURE 3.0 ICTUS 4.0 EPILEPSY 5.0 FOCAL 6.0 GENERALIZED 7.0 CONVULSION II TERMS DESCRIBING EPILEPTIC SEIZURE SEMIOLOGY 1.0 MOTOR 1.1 ELEMENTARY MOTOR 1.1.1 TONIC 1.1.1.1 EPILEPTIC SPASM 1.1.1.2 POSTURAL 1.1.1.2.1 VERSIVE 1.1.1.2.2 DYSTONIC 1.1.2 MYOCLONIC 1.1.2.1 NEGATIVE MYOCLONIC 1.1.2.2 CLONIC 1.1.2.2.1 JACKSONIAN MARCH 1.1.3 TONIC-CLONIC 1.1.3.1 GENERALIZED TONIC-CLONIC SEIZURE 1.1.4 ATONIC 1.1.5 ASTATIC 1.1.6 SYNCHRONOUS 1.2 AUTOMATISM 1.2.1 OROALIMENTARY 1.2.2 MIMETIC 1.2.3 MANUAL OR PEDAL 1.2.4 GESTURAL 1.2.5 HYPERKINETIC 1.2.6 HYPOKINETIC 1.2.7 DYSPHASIC 1.2.8 DYSPRAXIC 1.2.9 GELASTIC 1.2.10 DACRYSTIC 1.2.11 VOCAL 1.2.12 VERBAL 1.2.13 SPONTANEOUS 1.2.14 INTERACTIVE 2.0 NON-MOTOR 2.1 AURA 2.2 SENSORY 2.2.1 ELEMENTARY 2.2.1.1 SOMATOSENSORY 2.2.1.2 VISUAL 2.2.1.3 AUDITORY 2.2.1.4 OLFACTORY 2.2.1.5 GUSTATORY 2.2.1.6 EPIGASTRIC 2.2.1.7 CEPHALIC 2.2.1.8 AUTONOMIC 2.2.2 EXPERIENTIAL 2.2.2.1 AFFECTIVE 2.2.2.2 MNEMONIC 2.2.2.3 HALLUCINATORY 2.2.2.4 ILLUSORY 2.3 DYSCOGNITIVE 3.0 AUTONOMIC EVENTS 3.1 AUTONOMIC AURA 3.2 AUTONOMIC SEIZURE 4.0 SOMATOTOPIC MODIFIERS 4.1 LATERALITY 4.1.1 UNILATERAL 4.1.1.1 HEMI4.1.2 GENERALIZED (syn. “bilateral”) 4.1.2.1 ASYMMETRICAL 4.1.2.2 SYMMETRICAL 4.2 BODY PART 4.3 CENTRICITY 4.3.1 AXIAL Epilepsia, 42(9):1212–1218, 2001 Blackwell Science, Inc.


Epilepsia | 2003

Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery

Wieser Hg; Warren T. Blume; D. Fish; Eli S. Goldensohn; A. Hufnagel; Don W. King; Michael R. Sperling; Hans O. Lüders

*Neurology Clinic, Epileptology & EEG, University Hospital, Zurich, Switzerland; †Department of Neurology, University Hospital, London, Ontario, Canada; ‡The National Hospital for Neurology and Neurosurgery, Queen Square, London, England; §Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, New York, U.S.A.; Department of Neurology, University of Essen, Essen, Germany; ¶Department of Neurology, Medical College of Georgia, Augusta, Georgia; **Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania; and ††Department of Neurology, The Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A.


Lancet Neurology | 2009

Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology

Alexis Arzimanoglou; Jacqueline A. French; Warren T. Blume; J. Helen Cross; Jan Peter Ernst; Martha Feucht; Pierre Genton; Renzo Guerrini; Gerhard Kluger; John M. Pellock; Emilio Perucca; James W. Wheless

Lennox-Gastaut syndrome is one of the most severe epileptic encephalopathies of childhood onset. The cause of this syndrome can be symptomatic (ie, secondary to an underlying brain disorder) or cryptogenic (ie, has no known cause). Although Lennox-Gastaut syndrome is commonly characterised by a triad of signs, which include multiple seizure types, slow spike-wave complexes on electroencephalographic (EEG) recordings, and impairment of cognitive function, there is debate with regard to the precise limits, cause, and diagnosis of the syndrome. Tonic seizures, which are thought to be a characteristic sign of Lennox-Gastaut syndrome, are not present at onset and the EEG features are not pathognomonic of the disorder. There are few effective treatment options for the multiple seizures and comorbidities, and the long-term outlook is poor for most patients. Probably as a result of the complexity of the disorder, only a few randomised trials have studied Lennox-Gastaut syndrome, and thus many of the drugs that are more commonly used have little or no supporting evidence base from controlled trials. In this Review, we discuss the main issues with regard to the diagnosis and treatment options available. We also suggest key considerations for future trials and highlight the importance of a comprehensive approach to the assessment and management of this syndrome.


Epilepsia | 1999

Stereotactic amygdalohippocampotomy for the treatment of medial temporal lobe epilepsy.

Andrew G. Parrent; Warren T. Blume

Summary: Purpose: This study was carried out to assess the safety and efficacy of stereotactic ablation of the amygdala and hippocampus for the treatment of medial temporal lobe epilepsy.


Epilepsia | 2004

Indices of Resective Surgery Effectiveness for Intractable Nonlesional Focal Epilepsy

Warren T. Blume; Gobi R. Ganapathy; David Munoz; Donald H. Lee

Summary:u2003 Among 70 patients with intractable focal epilepsy and no specific lesion, as determined by both MRI (magnetic resonance imaging) and histopathology, outcome after resective surgery was polarized: 26 (37%) became seizure free (SF), and 27 (39%) were not helped. Eighteen (42%) of 43 standard temporal resections rendered patients SF, somewhat more than eight (30%) of 27 other procedures. To seek reliable prognostic factors, the subsequent correlative data compared features of the 26 SF patients with those of the 27 not helped. Although ictal semiology guided the site of surgical resection, it and other aspects of seizure and neurologic history failed to predict surgical outcome. However, two aspects of preoperative scalp EEGs correlated with SF outcomes: (a) among 25 patients in whom >50% of clinical seizures arose from the later resected lobe and no other origins, 18 (72%) became SF compared with seven (28%) of 25 with other ictal profiles; (b) 13 (93%) of 14 temporal lobe patients whose interictal and ictal EEGs lacked features indicative of multifocal epileptogenesis became SF compared with five (33%) of 15 with such components. The considered need for subdural (SD) EEG reduced SF outcome from 18 (90%) of 20 patients without SD to eight (24%) of 33 with SD; this likely reflected an insufficient congruity of ictal semiology and interictal and ictal scalp EEG for localizing epileptogenesis. Within this SD group, >50% of clinical seizure origins from a later resected lobe increased SF outcome somewhat: from two (14%) of 14 without this attribute to six (40%) of 15 with it; 100% of such origins increased SF outcome from two (12%) of 16 to six (46%) of 13.


Epilepsia | 2006

The Progression of Epilepsy

Warren T. Blume

Summary:u2002 Prognosis for seizure control and cognitive development varies considerably among syndromes. Several factors may interact to influence outcome of an epilepsy including a causative etiology, ictal and interictal discharges, seizure‐related trauma or systemic perturbations, and antiepileptic drug (AED) effects. Clinical evidence convincingly supporting Gowers hypothesis that seizures beget seizures is lacking. Short‐term seizure suppression by early treatment does not appear to influence long‐term prognosis.


Epilepsy Research | 2002

Divalproex extended-release versus the original divalproex tablet: results of a randomized, crossover study of well-controlled epileptic patients with primary generalized seizures.

Manon Thibault; Warren T. Blume; Jean-Marc Saint-Hilaire; Rafik Zakhari; Kenneth W. Sommerville

PURPOSEnTo compare the safety and efficacy of two formulations of divalproex, extended-release divalproex versus the original divalproex tablet, in adolescent and adult patients with epilepsy.nnnMETHODSnEligible patients were between the ages of 12 and 65 years with primary generalized epilepsy, which was controlled over the month prior to study enrollment with divalproex or valproic acid 1000 mg to 2000 mg/day. The patients were well-controlled; 39 of 43 (91%) had no seizures in the previous year. Patients were randomized to receive 84 days of either divalproex two times a day (b.i.d.)/three times a day (t.i.d.) or extended-release divalproex qd and then (crossed over to) 84 days of the comparator formulation. During the two treatment periods, patients received the same daily dose equivalent of divalproex as was taken during the month prior to study entry. The clinical status of patients was evaluated at a screening visit and at four subsequent visits conducted every 42 days.nnnRESULTSnThere was no statistically significant difference between the formulation groups for seizure control rate (95% [41/43] for divalproex and 93% [40/43] for extended-release divalproex). Likewise, the formulation groups were similar based on the incidence of treatment-related adverse events. The most frequently reported (< or =11.4% for either formulation) treatment-related adverse events were asthenia, tremor, nausea, and dizziness.nnnCONCLUSIONSnExtended-release divalproex was similar to divalproex for the treatment of well-controlled, primary generalized epilepsy in terms of overall safety and efficacy parameters.


Neuropsychologia | 2004

Spared somatomotor and cognitive functions in a patient with a large porencephalic cyst revealed by fMRI.

James Danckert; Seyed M. Mirsattari; Stacey Danckert; Samuel Wiebe; Warren T. Blume; David P. Carey; Ravi S. Menon; Melvyn A. Goodale

To date functional magnetic resonance imaging (fMRI) has not been extensively used in presurgical evaluation of patients with intractable epilepsy. Patient S.P. presented with left frontal originating seizures, secondary to a large porencephalic cyst that encompassed much of his occipital and temporal cortex and a substantial portion of ipsilateral parietal cortex. Nevertheless, S.P. did not demonstrate any gross impairments of praxis or speech. Scalp electroencephalogram (EEG) telemetry revealed reduced background activity in the left hemisphere, an absence of identifiable normal sleep states, and confirmed the left frontal origin of his seizures with a prolonged postictal state, suggesting that the remaining cortex in S.P.s left hemisphere did not function normally despite his apparently normal appearance. Dichotic listening results also suggested that S.P. had an atypical language representation suggestive of either bilateral or right hemisphere speech representation. Surgical intervention to remove the remaining left hemisphere cortex was a serious consideration for treatment of S.P.s seizures. We used fMRI to evaluate whether or not the remaining cortex in S.P.s left hemisphere supported any cognitive or motor functions. Even though the volume of cerebral cortex was severely reduced and displaced in the left hemisphere, fMRI revealed significant activation in this remaining tissue in response to motor, somatosensory, and word generation tasks. In other words, we were able to demonstrate using fMRI that the remaining tissue in S.P.s left hemisphere continued to support some motor and cognitive functions. The possible implications of these findings in terms of functional reorganisation are discussed briefly.


Canadian Journal of Neurological Sciences | 2002

Invited review: clinical and basic neurophysiology of generalised epilepsies.

Warren T. Blume

Electroencephalography (EEG) clarifies several aspects of generalised epileptic seizures and epilepsies. For the clinician, it assists in the diagnosis of the epileptic condition and helps assign the disorder to an appropriate syndrome. This assignation and the quantity of epileptic discharges estimate severity and prognosis. When combined with relevant basic science investigations, EEG studies may disclose significant pathophysiological mechanisms. Therefore, this paper first describes EEG characteristics of the several disorders included under the broad category of generalised. The review then relates these phenomena to germane experimental data intending that this binocular survey will provide a more meaningful perspective of these disorders.


Journal of Neurosurgery | 2017

Awake perimetry testing for occipital epilepsy surgery

Holger Joswig; John P. Girvin; Warren T. Blume; Jorge G. Burneo; David A. Steven

With the patient awake during surgery, the authors used a simple technique to determine which part of a patients brain was essential for vision. This technique allows the surgeon to remove as much as the seizure-producing brain as possible by avoiding the areas that are critical for vision.

Collaboration


Dive into the Warren T. Blume's collaboration.

Top Co-Authors

Avatar

John P. Girvin

University of Western Ontario

View shared research outputs
Top Co-Authors

Avatar

Hans O. Lüders

Case Western Reserve University

View shared research outputs
Top Co-Authors

Avatar

Jerome Engel

University of California

View shared research outputs
Top Co-Authors

Avatar

Andrew G. Parrent

University of Western Ontario

View shared research outputs
Top Co-Authors

Avatar

Carlo Tassinari

London Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar

David A. Steven

University of Western Ontario

View shared research outputs
Top Co-Authors

Avatar

David Munoz

London Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar

Donald H. Lee

University of Western Ontario

View shared research outputs
Top Co-Authors

Avatar

Gobi R. Ganapathy

London Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge